Overview A Study of Experimental Medication BMS-986036 Given to Healthy Participants Status: Completed Trial end date: 2018-05-02 Target enrollment: Participant gender: Summary This is a study of experimental medication BMS-986036 given to healthy participants. Phase: Phase 1 Details Lead Sponsor: Bristol-Myers Squibb